This association remained significant after adjustment for demographic parameters, CKD-specific factors, inflammation, ESA use, iron supplementation, and mineral metabolism parameters, suggesting a robust association between anemia and higher total FGF23 values. The gene discussed is FGF23; the disease is anemia.